Expression of osteopontin and its receptors in ameloblastomas

被引:6
|
作者
Wang, Yi-Ping [1 ]
Liu, Bu-Yuan [1 ]
机构
[1] Natl Taiwan Univ, Coll Med, Natl Taiwan Univ Hosp, Dept Dent,Sch Dent,Grad Inst Clin Dent, Taipei 10048, Taiwan
关键词
Ameloblastoma; Osteopontin; Integrin alpha(v); CD44v6; INTEGRIN-BINDING LIGAND; LINKED GLYCOPROTEINS SIBLINGS; BONE SIALOPROTEIN; CD44; PROTEINS; CELLS; OSTEOCLASTS; METASTASIS; ACTIVATION; VARIANTS;
D O I
10.1016/j.oraloncology.2008.07.015
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
This study used an immunohistochemical method to examine the expression of osteopontin (OPN) in 30 ameloblastomas and of integrin alpha(v) and CD44v6 in 20 of these 30 ameloblastomas. We found that the positive staining rate in ameloblastomas was 87% for OPN, 45% for integrin alpha(v), and 90% for CD44v6. Both ameloblast-like and stellate reticulum-like cells showed a high expression of OPN and CD44v6. There was also a strong integrin av immunostaining on the cell membrane of osteoclasts. Binding of OPN to osteoclast cell membrane receptor integrin av can activate the osteoclast and increase its osteolytic activity. In addition, binding of OPN to ameloblastoma tumor cell membrane receptor CD44v6 can enhance tumor cell migration, invasion and spread. Therefore, we suggest that the local aggressive behavior and high osteolytic ability of ameloblastomas in the jawbones can be explained by the high expression of OPN and CD44v6 in ameloblastoma cells and the high expression of integrin av in osteoclasts. (C) 2008 Elsevier Ltd. All rights reserved.
引用
收藏
页码:538 / 542
页数:5
相关论文
共 50 条
  • [1] Expression of midkine in ameloblastomas and its correlation with clinicopathologic parameters
    Scheper, Mark A.
    Duarte, Eliza C. B.
    Intapa, Chaidan
    Zhang, Ming
    Nascimento, Lenin M.
    Almeida, Thauanne P.
    Gomes, Ana C.
    Song, Sharon
    Chaisuparat, Risa
    Batista, Aline C.
    Jham, Bruno C.
    ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY, 2012, 114 (04): : 497 - 502
  • [2] Expression, roles, receptors, and regulation of osteopontin in the kidney
    Xie, YS
    Sakatsume, M
    Nishi, S
    Narita, I
    Arakawa, M
    Gejyo, F
    KIDNEY INTERNATIONAL, 2001, 60 (05) : 1645 - 1657
  • [3] Calretinin expression in ameloblastomas
    Altini, M
    Coleman, H
    Doglioni, C
    Favia, G
    Maiorano, E
    HISTOPATHOLOGY, 2000, 37 (01) : 27 - 32
  • [4] Immunohistochemical Expression of Survivin and Its Relationship with Cell Apoptosis and Proliferation in Ameloblastomas
    Gonzalez-Gonzalez, Rogelio
    Molina-Frechero, Nelly
    Damian-Matsumura, Pablo
    Salazar-Rodriguez, Sirced
    Bologna-Molina, Ronell
    DISEASE MARKERS, 2015, 2015
  • [5] Enhanced expression of podoplanin in ameloblastomas
    Gonzalez-Alva, Patricia
    Tanaka, Akio
    Oku, Yuka
    Miyazaki, Yuji
    Okamoto, Eri
    Fujinami, Masahiro
    Yoshida, Noriaki
    Kikuchi, Kentaro
    Ide, Fumio
    Sakashita, Hideaki
    Kusama, Kaoru
    JOURNAL OF ORAL PATHOLOGY & MEDICINE, 2010, 39 (01) : 103 - 109
  • [6] Investigation of osteopontin levels and genomic variation of osteopontin and its receptors in Type 1 diabetes mellitus
    Z. Karamizadeh
    E. Kamali Sarvestani
    F. Saki
    H. Karamifar
    G.-H. Amirhakimi
    M. H. Namavar Shooshtarian
    S. Ashkani-Esfahani
    Journal of Endocrinological Investigation, 2013, 36 : 1090 - 1093
  • [7] Investigation of osteopontin levels and genomic variation of osteopontin and its receptors in Type 1 diabetes mellitus
    Karamizadeh, Z.
    Sarvestani, E. Kamali
    Saki, F.
    Karamifar, H.
    Amirhakimi, G-H.
    Shooshtarian, H. Namavar
    Ashkani-Esfahani, S.
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2013, 36 (11) : 1090 - 1093
  • [8] Differential regulation of osteopontin and its receptors in the postischemic hippocampus of rats
    Kim, HY
    Choi, JS
    Lee, MY
    JOURNAL OF NEUROCHEMISTRY, 2005, 94 : 178 - 179
  • [9] EXPRESSION OF OSTEOPONTIN IN HUMAN GLIOMA - ITS CORRELATION WITH THE MALIGNANCY
    SAITOH, Y
    KURATSU, J
    TAKESHIMA, H
    YAMAMOTO, S
    USHIO, Y
    LABORATORY INVESTIGATION, 1995, 72 (01) : 55 - 63
  • [10] Calcitonin receptors and osteopontin expression are markers in primary breast cancers.
    Thomas, R
    Pu, ZY
    Zhou, H
    Martin, TJ
    Findlay, DM
    Gillespie, MT
    JOURNAL OF BONE AND MINERAL RESEARCH, 1997, 12 : F394 - F394